Locations
United States · South San Francisco, CA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2019
Mirvie is a biotech company that leverages its innovative RNA platform to predict pregnancy complications such as preeclampsia and preterm birth months in advance through a simple blood test. This proactive approach enables personalized and preventive care, allowing mothers and healthcare providers to intervene before complications escalate into crises. With a focus on transforming maternal-fetal health, Mirvie aims to empower families with vital insights into pregnancy health, backed by landmark research and ongoing clinical studies. The company is positioned to make a significant impact in the pregnancy health market, addressing a critical need for early detection and intervention.
Something looks off?